Literature DB >> 15749716

Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear.

Saori Oka1, Shin Yanagimoto, Shinobu Ikeda, Maiko Gokoh, Seishi Kishimoto, Keizo Waku, Yoshio Ishima, Takayuki Sugiura.   

Abstract

2-Arachidonoylglycerol is an endogenous ligand for the cannabinoid receptors. Two types of cannabinoid receptors have been identified to date. The CB1 receptor is abundantly expressed in the brain, and assumed to be involved in the attenuation of neurotransmission. On the other hand, the physiological roles of the CB2 receptor, mainly expressed in several types of inflammatory cells and immunocompetent cells, have not yet been fully elucidated. In this study, we investigated possible pathophysiological roles of the CB2 receptor and 2-arachidonoylglycerol in acute inflammation in mouse ear induced by the topical application of 12-O-tetradecanoylphorbol-13-acetate. We found that the amount of 2-arachidonoylglycerol was markedly augmented in inflamed mouse ear. In contrast, the amount of anandamide, another endogenous cannabinoid receptor ligand, did not change markedly. Importantly, 12-O-tetradecanoylphorbol-13-acetate-induced ear swelling was blocked by treatment with SR144528, a CB2 receptor antagonist, suggesting that the CB2 receptor is involved in the swelling. On the other hand, the application of AM251, a CB1 receptor antagonist, exerted only a weak suppressive effect. The application of SR144528 also reduced the 12-O-tetradecanoylphorbol-13-acetate-induced production of leukotriene B(4) and the infiltration of neutrophils in the mouse ear. Interestingly, the application of 2-arachidonoylglycerol to the mouse ear evoked swelling, which was abolished by treatment with SR144528. Nitric oxide was suggested to be involved in the ear swelling induced by 2-arachidonoylglycerol. These results suggest that the CB2 receptor and 2-arachidonoylglycerol play crucial stimulative roles during the course of inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749716     DOI: 10.1074/jbc.M413260200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

2.  Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?

Authors:  Jürg Gertsch
Journal:  Commun Integr Biol       Date:  2008

3.  Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.

Authors:  Zhiyuan Wu; Pin Shao; Shaojuan Zhang; Mingfeng Bai
Journal:  J Biomed Opt       Date:  2014-03       Impact factor: 3.170

Review 4.  Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder.

Authors:  Mariah M Wu; Xinwen Zhang; Melissa J Asher; Stanley A Thayer
Journal:  Brain Res       Date:  2019-09-17       Impact factor: 3.252

5.  The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.

Authors:  Alexandre A Steiner; Alla Y Molchanova; M Devrim Dogan; Shreya Patel; Erika Pétervári; Márta Balaskó; Samuel P Wanner; Justin Eales; Daniela L Oliveira; Narender R Gavva; M Camila Almeida; Miklós Székely; Andrej A Romanovsky
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

6.  Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats.

Authors:  T Croci; E Zarini
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

Review 7.  CB₂: therapeutic target-in-waiting.

Authors:  Brady K Atwood; Alex Straiker; Ken Mackie
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-12-09       Impact factor: 5.067

Review 8.  Lipidomic analysis of endocannabinoid metabolism in biological samples.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-01-14       Impact factor: 3.205

9.  2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

Authors:  François Chouinard; Caroline Turcotte; Xiaochun Guan; Marie-Chantal Larose; Samuel Poirier; Line Bouchard; Véronique Provost; Louis Flamand; Nathalie Grandvaux; Nicolas Flamand
Journal:  J Leukoc Biol       Date:  2012-12-12       Impact factor: 4.962

10.  Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.

Authors:  J Desroches; J Guindon; C Lambert; P Beaulieu
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.